Does therapy with immunosuppressive drugs improve gastrointestinal symptoms in patients with systemic sclerosis?

Lea StammAlexandru GaraimanMike Oliver Becker Cosimo Bruni Rucsandra Dobrota Muriel ElhaiSherif IsmailSuzana JordanNorina ZampattiAurora Maria TatuOliver Distler Carmen-Marina Mihai

Published in: RMD open (2024)

Immunosuppressive treatment was associated with lower GIT scores in our cohort, which suggests the potential effects of immunosuppressants on GI manifestations in patients with SSc, requiring confirmation in prospective randomised clinical trials.

Keyphrases

systemic sclerosis
clinical trial
interstitial lung disease
open label
double blind
study protocol
phase ii
stem cells
rheumatoid arthritis
mesenchymal stem cells
replacement therapy
combination therapy
phase iii
human health
idiopathic pulmonary fibrosis
bone marrow
drug induced